ALEMBIC PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/04/2020 ,inter alia, to consider and approve With reference to the captioned matter, the exchange is hereby informed that a Meeting of Board of Directors of the Company will be held on Thursday, 23rd April, 2020, inter-alia to consider and approve Unaudited Financial Results of the Company for the quarter and financial year ended 31st March, 2020 in order to enable the Company to timely disseminate the financial results.

Due to present situation, the audit or limited review by Statutory Auditors is not possible. Therefore, the Company will be subsequently furnishing the Audited Financial Results for the quarter and financial year ended 31st March, 2020 in accordance with the provisions of Regulation 33, Regulation 52 and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Pursuant to the Company's Code of Conduct, the trading window for dealing in securities of the Company was closed from 1st April, 2020.

We request you to kindly take the same on record.